GenMark Diagnostics Reports 23 Percent Revenue Increase in Q2

Aug 05, 2019

|

NEW YORK – GenMark Diagnostics reported after the close of the market on Monday a 23 percent increase in second quarter revenues, driven by strong placements of its ePlex analyzer.

Separately, the company said in a filing with the US Securities and Exchange Commission that it has entered into an equity distribution agreement with Canaccord Genuity relating to shares of the diagnostic firm's common stock. Under the terms of the agreement, GenMark may offer and sell shares of its common stock having an aggregate value of up to $35 million at an offering price of $6.03 per share.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Diversity of African Genomes

New research shows that scientists need to do a better job of including a wider diversity of African genomes in their analyses, STAT says.

'We Gotta Change These Numbers'

A new paper in Science shows that men are still winning a large majority of the most sought-after NIH grants.

Science Like a Girl

Nature Research and the Estée Lauder Companies are awarding efforts to encourage girls to pursue careers in the STEM fields.

Science Looks at Beneficial Genetic Variants in the Melanesian Population, and More

In Science this week: beneficial genetic variants inherited from archaic Neanderthal and Denisovan hominins, and more.

Featured White Papers

Analytical Validation of the Oncomine Pan-Cancer Cell-Free Assay

A High-Performance Solution Combining CleanPlex OncoZoom Cancer Hotspot Panel and SOPHiA AI for Rapid Characterization of Somatic Mutations

Benchmarking of the Microsart AMP Mycoplasma Kit with Products of Two Other Suppliers

Genetic Testing as a Tool for Improving Care and Outcomes for Patients with Rare Inherited Retinal Diseases

Oct

21

Featured Webinar

Broad Genomic Testing for Oncology Clinical Trials and Clinical Practice

Genomics is a key element in the potential of precision medicine to transform oncology.

Oct

23

Featured Webinar

Single-Cell Methylation Profiling of Pediatric Tumors via a Unique NGS-based Approach

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.

Oct

24

Featured Webinar

Designing, Decoding & Delivering on Genetic Testing for Inherited Disease at Versiti

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.

Nov

04

Featured Webinar

Digital Solutions for NGS Genotyping – Accuracy, Clinical Relevancy, and Report Generation

This webinar will provide a look at how the Institute of Hematopathology in Hamburg, Germany, is implementing complex genomic testing for lung cancer.

Menu